Agios Pharmaceuticals, Inc. (AGIO)
33.60
-0.04
(-0.12%)
USD |
NASDAQ |
Sep 11, 16:00
33.59
-0.01
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Price to Book Value : 1.952 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 1.952 |
| September 10, 2026 | 1.954 |
| September 09, 2026 | 2.012 |
| September 08, 2026 | 1.949 |
| September 04, 2026 | 1.923 |
| September 03, 2026 | 1.925 |
| September 02, 2026 | 1.983 |
| September 01, 2026 | 1.987 |
| August 31, 2026 | 1.957 |
| August 28, 2026 | 1.936 |
| August 27, 2026 | 1.991 |
| August 26, 2026 | 1.975 |
| August 25, 2026 | 1.969 |
| August 24, 2026 | 1.896 |
| August 21, 2026 | 1.922 |
| August 20, 2026 | 1.954 |
| August 19, 2026 | 2.040 |
| August 18, 2026 | 1.998 |
| August 17, 2026 | 1.954 |
| August 14, 2026 | 1.950 |
| August 13, 2026 | 1.944 |
| August 12, 2026 | 1.987 |
| August 11, 2026 | 1.899 |
| August 10, 2026 | 1.893 |
| August 07, 2026 | 1.875 |
| Date | Value |
|---|---|
| August 06, 2026 | 1.856 |
| August 05, 2026 | 1.843 |
| August 04, 2026 | 1.836 |
| August 03, 2026 | 1.774 |
| July 31, 2026 | 1.744 |
| July 30, 2026 | 1.903 |
| July 29, 2026 | 2.034 |
| July 28, 2026 | 2.091 |
| July 27, 2026 | 2.148 |
| July 24, 2026 | 2.112 |
| July 23, 2026 | 2.108 |
| July 22, 2026 | 2.094 |
| July 21, 2026 | 2.170 |
| July 20, 2026 | 2.327 |
| July 17, 2026 | 2.301 |
| July 16, 2026 | 2.249 |
| July 15, 2026 | 2.316 |
| July 14, 2026 | 2.319 |
| July 13, 2026 | 2.356 |
| July 10, 2026 | 2.395 |
| July 09, 2026 | 2.486 |
| July 08, 2026 | 2.484 |
| July 07, 2026 | 2.557 |
| July 06, 2026 | 2.172 |
| July 02, 2026 | 2.183 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.666 |
| Biogen, Inc. | 1.702 |
| Insmed, Inc. | 37.29 |
| Alnylam Pharmaceuticals, Inc. | 24.56 |
| Regeneron Pharmaceuticals, Inc. | 2.548 |
Price to Book Value Related Metrics
| PS Ratio | 20.05 |
| Price | 33.60 |
| Earnings Yield | -20.86% |
| Market Cap | 2.003B |